8-6-13 11:32 AM EDT | Email Article

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, will present data from its studies of peripheral arterial disease (PAD), as well as offer educational sessions, at the upcoming AMP (Amputation Prevention) Symposium in Chicago, August 8-10.

AMP Podium Presentations

CSI will present data about orbital atherectomy in the treatment of PAD during the following podium presentations at AMP:

Thursday, Aug. 8

  • 10:50 – 11 a.m., Dr. George L. Adams, Rex Healthcare and University of North Carolina Health Systems, Garner, N.C.: “Orbital Atherectomy ATK and BTK”
  • 11 – 11:10 a.m., Dr. Jihad Mustapha, Metro Heart & Vascular, Wyoming, Mich.: Taped case presentation: “Orbital Atherectomy”
  • 11:18 – 11:26 a.m., Dr. Raymond Dattilo, St. Francis Health Center, Manhattan, Kan.: “Distal Protection Devices: Are They Needed During Atherectomy Cases?”

Friday, Aug. 9

  • 1:13 – 1:21 p.m., Dr. Jihad Mustapha: Tibiopedal Arterial Minimally Invasive (TAMI) Retrograde Revascularization – TAMI Technique

Saturday, Aug. 10

  • 8:28 – 8:38 a.m., Dr. Raymond Dattilo: “The Wrath of Calcification in CLI Patients: How Does It Impact Diagnostic Modalities and Revascularization Options?”
  • 11:34 – 11:40 a.m., Dr. George Adams: “Orbital Atherectomy in 6 Minutes”
  • 1:44 – 1:51 p.m., Dr. Raymond Dattilo: “Is Calcium a Major Barrier for Drug Eluting Delivery and What Are the Solutions to Improve Drug Delivery?”

AMP Poster Sessions

The following posters will be featured at AMP, Thursday, Aug. 8, through Saturday, Aug. 10, from 7:30 a.m. to 6 p.m.:

  • Dr. George L. Adams, Rex Healthcare, Raleigh, NC: “Orbital Atherectomy Outcomes of the Claudicant Patient Population within the CONFIRM Series”
  • Dr. Tony Das, Cardiology and Interventional Vascular Associates, Dallas, Texas: “Orbital Atherectomy Outcomes of the Critical Limb Ischemia Patient Population within the CONFIRM Series”
  • Dr. Michael Lee, UCLA Medical Center, Los Angeles, Calif.: “Pooled Analysis of the CONFIRM Registries: Outcomes in Patients with Renal Disease Treated for Peripheral Arterial Disease with Orbital Atherectomy” and “Pooled Analysis of the CONFIRM Registries: Impact of Gender on Outcomes in Patients Treated for Peripheral Arterial Disease with Orbital Atherectomy”
 

Atherectomy Workshop and Cadaver Summit: Aug. 8

 

WHAT: CSI has provided an educational grant for a roundtable atherectomy workshop and cadaver course at AMP, featuring ultrasound guided tibial and pedal access followed by orbital atherectomy treatment.

 

WHEN:

  Thursday, Aug. 8, 1 – 5 p.m.
 

WHERE:

Roundtable Atherectomy Workshop
Grand Ballroom
Chicago Marriott Downtown – Magnificent Mile
540 N. Michigan Ave.
Chicago, IL
 
Atherectomy Summit Cadaver Course

6th Floor Indiana, Iowa, Michigan and Michigan State Rooms

Chicago Marriott Downtown – Magnificent Mile
540 N. Michigan Ave.
Chicago, IL
 
 

Lunch Symposium: Aug. 8

 

WHAT: Leading PAD physicians will share their expertise during a lunch symposium at AMP. The symposium will cover the many costs of calcium and the usage of orbital atherectomy for plaque modification, as well as successful treatment case studies, and more.

 

WHEN:

  Thursday, Aug. 8, 11:50 a.m. – 12:50 p.m.
 

WHERE:

Grand Ballroom
Chicago Marriott Downtown – Magnificent Mile
540 N. Michigan Ave.
Chicago, IL
 

SCHEDULE:

The Many Costs of Calcium, Dr. Lawrence Garcia, St. Elizabeth’s Medical Center, Boston, Mass.
 
The Orbital Atherectomy Revolution, Dr. Robert Vorhies, Cox Health Systems, Springfield, Mo.
 
The Orbital Evidence: Successful Orbital Atherectomy Treatment Case Studies, Dr. Jihad Mustapha
 
Q & Atherectomy
 

CSI Booth at AMP: Aug. 9 – 10

Visit CSI at booth #409, 9:15 a.m. – 6:30 p.m. Friday, Aug. 9 and 9:30 a.m. – 3:30 p.m. Saturday, Aug. 10 to meet the company’s calcium experts and learn more about CSI’s unique orbital technology.

About Peripheral Arterial Disease
As many as 8 million to 12 million Americans, most over age 65, suffer from PAD, which is caused by the accumulation of plaque in peripheral arteries (commonly the pelvis or leg) reducing blood flow. Symptoms include leg pain when walking or at rest. Left untreated, PAD can lead to severe pain, immobility, non-healing wounds and eventually limb amputation. With risk factors such as diabetes and obesity on the rise, the prevalence of PAD is growing faster than the rest of the population.

Millions of patients with PAD may benefit from treatment with orbital atherectomy utilizing the Stealth 360° and Diamondback 360°, minimally invasive catheter systems developed and manufactured by CSI. These systems use a diamond-coated crown, attached to an orbiting shaft, which sands away plaque while preserving healthy vessel tissue — a critical factor in preventing reoccurrences. Balloon angioplasty and stents have significant shortcomings in treating hard, calcified lesions. Stents are prone to fractures and high recurrence rates, and treatment of hard, calcified lesions often leads to vessel damage and suboptimal results.

About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in August 2007. To date, nearly 110,000 of CSI’s devices have been sold to leading institutions across the United States. CSI has also completed its ORBIT II Investigational Device Exemption clinical trial to evaluate the safety and effectiveness of its orbital technology in treating coronary arteries. The coronary system is limited by federal law to investigational use and is currently not commercially available in the United States.

For more information, visit the company’s website at www.csi360.com.

For Cardiovascular Systems, Inc.
Investor Relations, 651-259-2800
investorrelations@csi360.com
or
Sarah Wozniak, 651-259-1636
swozniak@csi360.com
or
Padilla Speer Beardsley:
Matt Sullivan, 612-455-1709
msullivan@padillaspeer.com
or
Dave Folkens, 612-455-1741
dfolkens@padillaspeer.com

Copyright Business Wire 2013
Add a Comment

News   More...

Securities related to this article
Cardiovascular Systems, Inc. View csii Stock Quote
Cardiovascular Systems, Inc. View csii Stock Quote
 
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Content Partners
Morningstar - 2013/8/6 - Cardiovascular Systems to Present PAD Data and Offer Educational Sessions at AMP Chicago 2013 Symposium
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Author |  Collection |  Interest |  Popularity

Previous: Cardiovascular Systems to Present ORBIT II Coronary Data at 2014 Cardiovascular Research Technologies Conference  |  Next: Cardiovascular Systems to Webcast Fiscal 2013 Fourth-Quarter Earnings Conference Call Wednesday, August 7